Please login to the form below

Not currently logged in
Email:
Password:

FTI Consulting appoints Andrew Ward

He joins the healthcare communications practice as managing director

Andrew WardFTI Consulting, a life science and healthcare communications practice, has appointed a new managing director in the form of Andrew Ward.

Ward joins the group from the Financial Times, where he was the pharmaceuticals correspondent for almost three years, covering the business, finance, science and regulation of the global pharmaceuticals and medical equipment industries.

Ben Atwell, senior managing director and global head of life sciences and healthcare at FTI Consulting Strategic Communications, said: “Andrew was one of the sector’s most respected reporters during his time covering healthcare, and brings invaluable global perspective to our prestigious client base.

“We look forward to benefiting from his deep media experience and welcoming him to our global team of over 50 healthcare experts.”

In his new role, Ward will broaden and deepen FTI Consulting’s client base globally.

He said: “I am excited to be joining the best communications practice in the healthcare sector.

“It is a difficult decision to leave the FT after 18 fantastic years but the opportunity to help industries was too good to turn down.”

6th April 2018

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Apex.co.uk Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...